Stay updated on PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial
Sign up to get notified when there's something new on the PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial page.

Latest updates to the PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial page
- Check5 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now shows a 403 Forbidden error, blocking access to the trial record details (MK-3475-042/KEYNOTE-042) and related content.SummaryDifference20%

- Check40 days agoChange DetectedThe page now includes a funding attribution for 2014 (U.S. NIH Grant/Contract) and shows an updated Revision: v3.6.6. The Plain Language Summary and the older Revision: v3.6.5 have been removed, resulting in a streamlined public-facing page.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, signaling a minor update to the page. There are no specific content changes described in the provided data.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page's revision tag changed from Revision: v3.6.3 to Revision: v3.6.4, indicating a small update to the backend or content. This does not alter the study details or results.SummaryDifference0.1%

- Check97 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing v3.6.2. This is a maintenance/version update that does not modify the substantive study information.SummaryDifference0.1%

- Check104 days agoChange DetectedA Plain Language Summary was added to the Study Details page to provide an accessible overview of the trial. The revision tag was updated to v3.6.2, reflecting the latest page update.SummaryDifference0.3%

Stay in the know with updates to PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial page.